Results 1 to 10 of about 124,550 (291)

The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. [PDF]

JACC Adv
Tzoumas A, Tapp D, Crousillat D, Honigberg MC, Rodriguez-Lozano PF, Aggarwal NR, Ebong IA, Briller J, De Oliveira GM, Harrington CM, Mohammed SF, Merz NB, Henry TD, Quesada O, ACC Cardiovascular Disease in Women Committee.   +14 more
europepmc   +2 more sources

One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction [PDF]

, 2016
Background—Heart failure with preserved ejection fraction has a complex pathophysiology and remains a therapeutic challenge. Elevated left atrial pressure, particularly during exercise, is a key contributor to morbidity and mortality.
Bergmann, Martin, Burkhoff, Dan, Doughty, Robert, Feldman, Ted, Hasenfuß, Gerd, Hausleiter, Jorg, Hayward, Christopher, Jondeau, Guillaume, Kaye, David M., Kolodziej, Adam, Muller, David, Neuzil, Petr, Penicka, Martin, Petrie, Mark C., Ponikowski, Piotr, Post, Martijn C., Raake, Philip, Rosenberg, Mark, Silvestry, Frank E., Trochu, Jean-Noël, van Veldhuisen, Dirk J., Walters, Darren, Walton, Antony, Westenfeld, Ralf   +23 more
core   +15 more sources

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction

Journal of Cardiovascular Development and Disease, 2023
(1) Background: Chronic inflammation and fibrosis are key players in cardiac remodeling associated with left ventricular hypertrophy (LVH) and heart failure with a preserved ejection fraction (HFpEF). Monocytes and T-helpers (Th) are involved in both pro-
Artem Ovchinnikov, Anastasiya Filatova, Alexandra Potekhina, Tatiana Arefieva, Anna Gvozdeva, Fail Ageev, Evgeny Belyavskiy   +6 more
doaj   +1 more source

Heart failure with preserved ejection fraction – onset [PDF]

Българска кардиология, 2021
During these more than 20 years of evolution in understandings of the mechanisms of heart failure (HF) with preserved fractional ejection, there has been a rich variety of terminology, including „diastolic heart failure“, „heart failure with preserved ...
Branimir Kanazirev
doaj   +3 more sources

Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine, 2022
BackgroundAlthough the predictive value of galectin-3 for heart failure with preserved ejection fraction has been demonstrated, the diagnostic value remains unclear.
Jing Jiang, Baojun Yang, Ying Sun, Jing Jin, Zhiying Zhao, Songming Chen   +5 more
doaj   +1 more source

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj   +1 more source

Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity

Frontiers in Physiology, 2022
Heart failure with preserved ejection fraction is a growing epidemic and accounts for half of all patients with heart failure. Increasing prevalence, morbidity, and clinical inertia have spurred a rethinking of the pathophysiology of heart failure with ...
Aneesh Dhore-patil, Aneesh Dhore-patil, Tariq Thannoun, Tariq Thannoun, Rohan Samson, Rohan Samson, Thierry H. Le Jemtel, Thierry H. Le Jemtel   +7 more
doaj   +1 more source

Comparing the Diagnostic Performance of HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry

Anatolian Journal of Cardiology, 2023
Background: Heart failure with preserved ejection fraction is a complex and heterogeneous clinical syndrome, poses significant diagnostic challenges.
Gurbet Özge Mert, Bülent Özlek, Eda Özlek, Hicaz Zencirkiran Ağuş, Mehmet Tekinalp, Serkan Kahraman, Cem Çil, Oğuzhan Çelik, Özcan Başaran, Volkan Doğan, Bedri Caner Kaya, İbrahim Rencüzoğulları, Altuğ Ösken, Lütfü Bekar, Mustafa Ozan Çakır, Yunus Çelik, Kadriye Memiç Sancar, Samet Sevinç, Murat Biteker, Kadir Uğur Mert   +19 more
doaj   +1 more source

Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review

Терапевтический архив, 2023
Heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction are associated with significant morbidity and mortality, as well as growing economic burden.
Igor V. Zhirov, Natalia V. Safronova, Sergey N. Tereshchenko   +2 more
doaj   +1 more source

Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction

Frontiers in Immunology, 2022
The incidence of heart failure with preserved ejection fraction is increasing in patients with obesity, diabetes, hypertension, and in the aging population. However, there is a lack of adequate clinical treatment.
Chenyu Li, Donglu Qin, Jiarui Hu, Yang Yang, Die Hu, Bilian Yu   +5 more
doaj   +1 more source